How Purdue Pharma Sold a Crisis: The OxyContin Scandal

In 1996, there were six hundred seventy thousand prescriptions for a new painkiller called OxyContin. Five years later, that number was over SIX million. It’s a pattern of explosive growth built on a hidden truth. Last week, you heard how a secret backdoor in FTX's code allowed an empire to be built on customer funds. This week, we're looking at a company built on a secret that was hidden in plain sight, printed right on the bottle. The company was Purdue Pharma. The owners were the Sackler family. And the product would make them billions, while creating a crisis that is still being paid for today. The story starts with a simple, powerful sales pitch.

A pitch that was a lie. Here’s how you build an empire on pain. First, you identify a market. In the nineties, that market was millions of Americans with chronic, non-cancer pain. Second, you create a product. Purdue took an existing opioid, oxycodone, and wrapped it in a time-release coating, calling it OxyContin. The genius, they claimed, was that the coating made it safer, less addictive. Third, and this is the key, you sell the idea. And Purdue sold it relentlessly. In 2001 alone, they spent two hundred million dollars on marketing. They sponsored over forty national “pain management symposia” in attractive destinations. They used data to find the highest-prescribing doctors and targeted them.

Sales representatives were trained to deliver one, critical message: the risk of addiction from OxyContin was, quote, “less than one percent.” That number came from a single, flawed paragraph in a 1980s medical journal that never studied long-term use. But it was the number they needed. It was the permission doctors needed to hear. And it worked. Prescriptions soared. The money poured in. So who benefits? The Sackler family. They personally drove the sales strategy, with court documents showing they accompanied sales reps on visits to doctors. They stood to gain everything. And by 2019, they had amassed a personal fortune of about fourteen billion dollars.

The lie wasn’t just a marketing slogan. It was the foundation of a dynasty. The company knew. Internal documents show Purdue was aware that crushing the pills defeated the time-release mechanism, a method of abuse. Executives later testified to Congress they were unaware of widespread abuse until the year 2000. But the evidence showed that was just another part of the story they were selling. The most telling detail is what the Sacklers did when the truth started to come out. As over a thousand lawsuits piled up from states and cities, the family began what one member called a “milking program.” They systematically pulled approximately eleven billion dollars out of Purdue Pharma over a decade.

They were protecting their personal wealth, moving it beyond the reach of the courts and their victims. It wasn't just about the money they had made. It was about the money they were determined to KEEP. This is a report on a historical case, not medical advice. Always consult a healthcare professional for any medical concerns. The end for Purdue Pharma came in 2019, when it filed for bankruptcy. This year, a seven point four billion dollar settlement finally became effective. The money will be paid out over fifteen years, funding addiction treatment and prevention programs across the country. The Sackler family is permanently barred from selling opioids in the United States.

The money from the settlement will now flow to the communities that were broken. But the case sets a new precedent. It proves that for corporate crimes of this scale, accountability isn't just a fine paid by a bankrupt company. It's a permanent mark on the family name that built the empire. And that, you can't move offshore.